Dequilinyl chloride + Lysozyme hydrochloride (Dequilinyl chloride + Lysozyme hydrochloride)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Antiseptics and disinfectants

Included in the formulation
  • Laripront
    pills n / az. 
    Hexalo Trieding Limited     Cyprus
    • АТХ:

    R.02.A.A   Antiseptics

    Pharmacodynamics:

    The drug has mucolytic, anti-inflammatory, antiviral and antimicrobial effect.

    Pharmacokinetics:

    Not described.

    Indications:

    Fungal and bacterial infections and inflammatory diseases of the mouth, larynx and pharynx. Periods before and after otolaryngological and dental operations.

    ICD-10

    X.J00-J06.J02.9   Acute pharyngitis, unspecified

    X.J00-J06.J03.9   Acute tonsillitis, unspecified

    X.J00-J06.J04   Acute laryngitis and tracheitis

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XI.K00-K14.K12   Stomatitis and related lesions

    Contraindications:

    Hypersensitivity.

    Carefully:

    During pregnancy and lactation.

    Pregnancy and lactation:

    Category FDA not determined.

    Dosing and Administration:

    Orally, 1 tablet for resorption for 30 minutes before meals every 2-3 hours. Within 30 minutes after taking the pill, eating is not recommended.

    Side effects:

    Allergic reactions.

    Overdose:

    Not described.

    Interaction:

    Not studied.

    Special instructions:

    Does not affect the ability to drive and other mechanisms.

    Instructions
    Up